Simplex Trading, LLC Voyager Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,904 shares of VYGR stock, worth $16,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,904
Previous 3,972 26.89%
Holding current value
$16,785
Previous $31,000 48.39%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$5.77 - $9.27 $6,162 - $9,900
-1,068 Reduced 26.89%
2,904 $16,000
Q2 2024

Jul 25, 2024
SELL
$7.42 - $10.54 $56,681 - $80,515
-7,639 Reduced 65.79%
3,972 $31,000
Q1 2024

Apr 25, 2024
BUY
$7.15 - $10.84 $83,018 - $125,863
11,611 New
11,611 $108,000
Q3 2023

Nov 01, 2023
BUY
$7.55 - $11.25 $57,168 - $85,185
7,572 New
7,572 $58,000
Q1 2023

Apr 27, 2023
BUY
$6.0 - $10.78 $99,738 - $179,195
16,623 New
16,623 $128,000
Q3 2021

Oct 28, 2021
BUY
$2.63 - $4.12 $1,904 - $2,982
724 New
724 $2,000
Q2 2021

Aug 12, 2021
SELL
$3.94 - $5.44 $10,409 - $14,372
-2,642 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$4.61 - $9.04 $12,179 - $23,883
2,642 New
2,642 $12,000
Q4 2020

Feb 02, 2021
SELL
$7.15 - $12.28 $10,474 - $17,990
-1,465 Closed
0 $0
Q3 2020

Oct 14, 2020
BUY
$10.01 - $13.75 $3,553 - $4,881
355 Added 31.98%
1,465 $15,000
Q2 2020

Jul 13, 2020
SELL
$8.05 - $14.21 $7,929 - $13,996
-985 Reduced 47.02%
1,110 $14,000
Q1 2020

Apr 29, 2020
SELL
$6.8 - $14.66 $57,820 - $124,653
-8,503 Reduced 80.23%
2,095 $19,000
Q4 2019

Feb 05, 2020
BUY
$12.82 - $16.85 $52,549 - $69,068
4,099 Added 63.07%
10,598 $147,000
Q3 2019

Oct 15, 2019
SELL
$16.31 - $28.29 $283,761 - $492,189
-17,398 Reduced 72.8%
6,499 $111,000
Q2 2019

Jul 26, 2019
BUY
$19.18 - $27.88 $151,157 - $219,722
7,881 Added 49.21%
23,897 $650,000
Q1 2019

Apr 18, 2019
BUY
$8.0 - $19.66 $127,344 - $312,947
15,918 Added 16242.86%
16,016 $0
Q4 2018

Jan 16, 2019
SELL
$8.59 - $18.05 $2,482 - $5,216
-289 Reduced 74.68%
98 $0
Q3 2018

Oct 23, 2018
BUY
$17.11 - $21.74 $1,950 - $2,478
114 Added 41.76%
387 $7,000
Q2 2018

Jul 30, 2018
SELL
$16.76 - $23.92 $1,676 - $2,392
-100 Reduced 26.81%
273 $5,000
Q1 2018

Apr 26, 2018
SELL
$16.16 - $31.31 $196,230 - $380,197
-12,143 Reduced 97.02%
373 $7,000
Q4 2017

Jan 10, 2018
BUY
$12.26 - $25.88 $148,468 - $313,406
12,110 Added 2982.76%
12,516 $207,000
Q3 2017

Oct 25, 2017
BUY
$8.37 - $20.59 $3,398 - $8,359
406
406 $8,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email